The effects of vitamin C supplementation on serum concentrations of uric acid - Results of a randomized controlled trial

被引:142
作者
Huang, HY
Appel, LJ
Choi, MJ
Gelber, AC
Charleston, J
Norkus, EP
Miller, ER
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Lady Mercy Med Ctr, Bronx, NY USA
来源
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 06期
关键词
D O I
10.1002/art.21105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Reductions in serum uric acid levels are clinically relevant. Previous studies have suggested a uricosuric effect of vitamin C. Whether vitamin C reduces serum uric acid is unknown. We undertook this study to determine the effects of vitamin C supplementation on serum uric acid concentrations. Methods. The study was a double-blinded placebo-controlled randomized trial conducted in research units affiliated with an academic institution. Study participants were 184 nonsmokers, randomized to take either placebo or vitamin C supplements (500 mg/day) for 2 months. Results. At the end of the study period, serum uric acid levels were significantly reduced in the vitamin C group (mean change -0.5 mg/dl [95% confidence interval -0.6, -0.3]), but not in the placebo group (mean change 0.09 mg/dl [95% confidence interval -0.05, 0.2]) (P < 0.0001). The same pattern of results was evident in subgroups defined by age, sex, race, body mass index, chronic illness, diuretic use, and quartiles of baseline serum ascorbic acid levels. In the subgroups, from the lowest to the highest quartile of baseline serum uric acid, net mean changes (95% confidence intervals) in serum uric acid with vitamin C supplementation were -0.4 (-0.8, 0.01), -0.5 (-0.9, -0.2), -0.5 (-0.8, -0.2), and -1.0 (-1.6, -0.4) mg/dl (P = 0.06, 0.005, 0.003, and 0.002, respectively). Compared with placebo, vitamin C increased the estimated glomerular filtration rate. Conclusion. Supplementation with 500 mg/day of vitamin C for 2 months reduces serum uric acid, suggesting that vitamin C might be beneficial in the prevention and management of gout and other urate-related diseases.
引用
收藏
页码:1843 / 1847
页数:5
相关论文
共 15 条
[1]   EFFECT OF ASCORBIC-ACID ON URIC-ACID EXCRETION WITH A COMMENTARY ON RENAL HANDLING OF ASCORBIC-ACID [J].
BERGER, L ;
GERSON, CD ;
YU, TF .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (01) :71-76
[2]  
Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4
[3]  
GOCHMAN N, 1971, CLIN CHEM, V17, P1154
[4]   Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial [J].
Huang, HY ;
Appel, LJ ;
Croft, KD ;
Miller, ER ;
Mori, TA ;
Puddey, IB .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (03) :549-555
[5]   Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects [J].
Iseki, K ;
Oshiro, S ;
Tozawa, M ;
Iseki, C ;
Ikemiya, Y ;
Takishita, S .
HYPERTENSION RESEARCH, 2001, 24 (06) :691-697
[6]   A role for uric acid in the progression of renal disease [J].
Kang, DH ;
Nakagawa, T ;
Feng, LL ;
Watanabe, S ;
Han, L ;
Mazzali, M ;
Truong, L ;
Harris, R ;
Johnson, RJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (12) :2888-2897
[7]   A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation [J].
Levey, AS ;
Bosch, JP ;
Lewis, JB ;
Greene, T ;
Rogers, N ;
Roth, D .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :461-+
[8]   TISSUE ASCORBIC-ACID ANALYSIS USING FERROZINE COMPARED WITH THE DINITROPHENYLHYDRAZINE METHOD [J].
MCGOWN, EL ;
RUSNAK, MG ;
LEWIS, CM ;
TILLOTSON, JA .
ANALYTICAL BIOCHEMISTRY, 1982, 119 (01) :55-61
[9]   EFFECT OF LARGE ORAL DOSES OF ASCORBIC-ACID ON URIC-ACID EXCRETION BY NORMAL SUBJECTS [J].
MITCH, WE ;
JOHNSON, MW ;
KIRSHENBAUM, JM ;
LOPEZ, RE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) :318-321
[10]   Hyperuricemia causes glomerular hypertrophy in the rat [J].
Nakagawa, T ;
Mazzali, M ;
Kang, DH ;
Kanellis, J ;
Watanabe, S ;
Sanchez-Lozada, LG ;
Rodriguez-Iturbe, B ;
Herrera-Acosta, J ;
Johnson, RJ .
AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (01) :2-7